Sava Infond D.O.O. Trans Medics Group, Inc. Transaction History
Sava Infond D.O.O.
- $566 Billion
- Q4 2024
A detailed history of Sava Infond D.O.O. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Sava Infond D.O.O. holds 1,500 shares of TMDX stock, worth $106,830. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$106,830% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
362Shares Held
31.1MCall Options Held
492KPut Options Held
344K-
Vanguard Group Inc Valley Forge, PA3.64MShares$259 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$188 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$96.9 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$71.2 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$70.7 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.27B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...